Lyophilization Equipment and Services Market Worth 4.80 Billion USD by 2020

The lyophilization equipment and services market is fragmented in nature, having a large count of small players and a meagre count of large players. The manufacturers operating in this market are constantly putting in efforts for the development and commercialization of new, improved, and cheaper technologies employing the long-term utilization of the lyophilization method. Azbil Telstar, S.L., BioPharma Solutions, and Biopharma Technology, Ltd., among others, are the key players in the global lyophilization equipment and services market. 

The global lyophilization equipment and services market is predicted to touch US$4,805.4 mn by 2020. In terms of equipment type, the segment of tray lyophilizers is predicted to lead the market all through 2020. The demand for this segment is on the rise owing to longer service life, corrosion resistance, ease of handling, optimum performance, and compact designs of tray lyophilizers. This segment is predicted to rise at a CAGR of 8.20% from 2014 to 2020.

Request a Free PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1502

Strong Demand for Lyophilization Equipment from Nutraceuticals to Drive Market Growth

By service type, bulk lyophilization segment held the leading share in the past and is predicted to maintain its superiority all through 2020. This is owing to large production capabilities associated with the use of bulk lyophilization service. Application-wise, there is a substantial demand for lyophilization equipment from the segment of nutraceuticals and this segment is predicted to expand at a CAGR of 8.60% between 2014 and 2020. There is an increasing demand for lyophilization equipment and services in both Europe and North America owing to the rising research activities in these two regions.

A number of biopharmaceuticals including biologics, peptides, enzymes, plasma, proteins, vaccines, and antibodies experience a huge demand owing to their high employment in life-saving medications. All these products undergo a number of chemical reactions such as aggregation, fragmentation, hydrolysis, etc., hence reducing their overall biological activity and resulting in degraded products. Thus, these substances are lyophilized for manufacturing high-quality products, hence boosting the growth of the lyophilization equipment and services market.

Growth in Contract Services Market to Increase Adoption of Lyophilization Equipment and Services

Furthermore, the cost and time reduction and an exponential product commercialization have fuelled the overall market for contract services. This has further enabled the manufacturers operating in nutraceuticals, biopharmaceuticals, and pharmaceuticals to outsource expensive procedures including lyophilization equipment and services, thus fuelling the growth of the overall market, stated TMR.

On the other hand, the process of lyophilization is immensely labor-intensive and costly and demands adept manpower for delivering high-quality products. In addition, the installation of freeze drying microscopy lab may incur substantial cost owing to the employment of components such as polarized-light microscope, liquid nitrogen-cooled thermal stage, imaging system, and , vacuum pump. Hence, the huge cost of installing a well-organized lyophilization facility may raise the cost of services. This factor may impede the development of the overall lyophilization equipment and services market, says a TMR analyst.

Nonetheless, the introduction of newer technologies such as precipitation, deep freeze drying, and vacuum freeze drying is a key opportunity in the market, Transparency Market Research (TMR) finds in its new study.

Browse Research Report on Global Lyophilization Equipment and Services Market:
http://www.transparencymarketresearch.com/lyophilization-equipment-services.html

Osteosynthesis Devices Market Expected to expand at a CAGR of 6.5% in 2023

Degradable and bioabsorbable osteosynthesis devices have reached a point in their commercialization cycle where they now carry the capability to transform the future of the global osteosynthesis devices market as a whole. Although the global osteosynthesis devices market is currently dominated by devices made from non-degradable materials—mainly metals—the future clearly belongs to degradable materials. This also explains why companies have trained their focus on developing innovative materials that can heal fractures and be gradually absorbed by the body. Besides the physical benefits that come along with degradable osteosynthesis devices, the economic benefits are also making them an attractive option – mainly because they eliminate the need for a second implant removal surgery. 

Request a Free PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5981

The global osteosynthesis devices market is expected to post strong gains in terms of both volume and value on account of a substantial increase in the number of osteoporosis and osteosynthesis cases reported worldwide. According to a study published by Transparency Market Research, revenue gains in the osteosynthesis devices market are expected to rise at a CAGR of 6.5% between 2015 and 2023. TMR’s valuation of the market by the end of 2023 is US$11.09 bn.

What strategies separate osteosynthesis devices market leaders from other smaller players?

Entering the global osteosynthesis devices market requires a massive economic and strategic effort for new players. The reasons for this can be illustrated with the following points:

• DePuy Synthes alone commanded over 48.6% of the osteosynthesis devices market in 2014. The company’s formidable stake in the market was a result of DePuy (Johnson & Johnson company) joining forces with Synthes to gain a wider presence in the market.
• The next leading player in the osteosynthesis devices market as of 2014 was Stryker Corporation, boasting nearly 24% of market revenues. The company has an expansive range of products, including but not limited to hip fixation devices and intramedullary nail devices.
• Nearly 11.6% of the osteosynthesis devices market, in 2014, was held by Zimmer Biomet. Although the company’s product portfolio comprises numerous non-degradable osteosynthesis devices, it is focusing on developing newer materials and devices that are safety-evaluated by leading agencies. 

The sizeable shares and well-established business network that the top three companies already occupy in the market leave the other companies to compete for what remains, making it difficult for new companies to make a foray into this space.

To what extent will product recalls dent the growth of the global osteosynthesis devices market?

Product recalls are arguably the biggest challenge for companies in the global osteosynthesis devices market. Besides recalls, lawsuits filed against leading players also mean that companies have to set aside appreciable portions of their revenues for legal battles and settlement fees. A case in point would DePuy Synthes’ recall of 93,000 implants in 2010. The company also had to shell out an estimated US$4 mn in settlement of lawsuits filed by patients who had undergone hip implants that had inherent problems. 

Metal implants continue to be a sore spot in the overall growth strategies of leading companies and this has forced them to look for more innovative materials and osteosynthesis devices. 

Browse Research Report on Global Osteosynthesis Devices Market:
http://www.transparencymarketresearch.com/osteosynthesis-devices-market.html

Clinical Laboratory Services Market to Reach US$241.3 bn by 2019 owing to Early Detection Capabilities of Numerous Specialized Diagnostic Tests

A new Transparency Market Research report states that the global clinical laboratory services market stood at US$162.7 bn in 2012 and is predicted to reach US$241.3 bn by 2019. It is predicted to expand at a CAGR of 5.80% from 2013 to 2019. The title of the report is “Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Request a Free PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=414
 
Clinical laboratories form an important part of the industry of healthcare owing to the fact that majority of the diagnosis carried on by physicians are dependent on these laboratory tests. Owing to the hospital stays of patients becoming shorter and the decreasing contact time amongst physicians and patients, clinical laboratory services are gaining demand. The demand for clinical laboratory services is also increasing owing to their great abilities of gathering, interpreting, and delivering adequate information to physicians. These services present a range of tests for detecting disease progression and abnormalities. These tests range from blood to routine urine tests to molecular expression testing, etc.

As per the report, the market for clinical laboratory services is fuelled by the increasing introduction of employer-sponsored wellness programs and the rising global aging population. In addition, the increasing occurrence of diseases and the early detection capabilities of numerous specialized diagnostic tests are also amongst the chief factors augmenting the growth of the market for clinical laboratory services. Furthermore, the launch of innovative solutions is a key growth opportunity in the market for clinical laboratory services. On the other hand, the strict regulatory scenario in a number of nations is the major factor that may impede the growth of the market in forthcoming years, as per this study.

The report segments the market in terms of service provider, test type, and geography.

On the basis of service provider, the report segments the market into clinic-based, standalone, and hospital-based clinical laboratory services. Amongst these, the segment of hospital-based laboratories is anticipated to continue its dominance in the forecast horizon owing to the greater testing volumes of these laboratories in comparison to standalone and clinic-based laboratory services. On the other hand, the segment of standalone laboratories has also gained a lot of popularity owing to their benefits, including the ease of access provided to patients and swift sample processing abilities. In terms of test type, the market for clinical laboratory services is segmented into clinical chemistry, human and tumor genetics, medical microbiology and cytology, and other esoteric tests.

Geographically, the report segments the market into North America, Europe, Asia Pacific, and Rest of the World (RoW). Amongst these, the region of Asia Pacific is predicted to exhibit rapid growth in the forecast horizon between 2013 and 2016 due to the huge population base having huge unmet medical requirements within this region. However, the Asia Pacific clinical laboratory services market is predicted to lose some of its share owing to the growing unorganized healthcare reimbursement and absence of a strict regulatory framework in this region. On the other hand, the region of North America leads the market for clinical laboratory systems on the basis of revenue and is anticipated to maintain its dominance throughout the forecast horizon owing to the supportive reimbursement scenario, the rising occurrence of diseases, and the advanced healthcare infrastructure within this region.

As stated in the report, the chief players dominant in the market for clinical laboratory services are Charles River Laboratories, Quest Diagnostics, Inc., Bio-Reference Laboratories, and Abbott Laboratories, among others.

Browse Research Report on Global Clinical Laboratory Services Market
http://www.transparencymarketresearch.com/clinical-laboratory-services-market.html

Commercialization of Nanotechnology Holds Lucrative Opportunities for Biomaterials Manufacturers, Reports TMR

The global biomaterials market for implantable devices is currently exhibiting a highly fragmented vendor landscape. The presence of a large number of companies has triggered intense rivalry among the existing players. As an inevitable response to the prevailing competition, these companies have been engaged in extensive research and development activities. Enterprises such as AdvanSource Biomaterials Corp., Celanese Corp., Celanese Corp., Evonik Industries AG, DuPont, and others have been investing in technological developments to rake in higher revenues.

Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2384

As per Transparency Market Research (TMR), the global biomaterials market is expected to rise at a CAGR of 4.1% between 2013 and 2019. The market was valued at US$25.2 bn in 2012 and is expected to reach US$33.6 bn by the end of 2019. Among the various biomaterial types available in the market, metals held a share of over 47.9% based on value in 2012.
 
Regionally, North America held over 44.4% of the global biomaterials market and is expected to maintain its dominance through the forecast period. An aging population and sedentary lifestyles of consumers in the region have spurred the chances of bone-related diseases, eye disorders, and fractures, which is in turn fuelling the demand for bone graft substitutes in North America. 

    

Advancements in Technology Have Bolstered Uptake of Medical Implants, thereby Fuelling Biomaterial Sales

Recent advancements in material science and the medical technology have been boosting the uptake of medical implants. These advances have helped in overcoming drawbacks of conventional procedures involving the use of implantable devices. For instance, with the advent of digital mapping technologies, orthopedic surgeons are now able to obtain precise measurements of bones during bone replacement surgeries. Such developments have created lucrative opportunities for biomaterial sales.

Overall, the market is expected to gain impetus from the rising demand for medical implants. “The use of medical implants for the treatment of musculoskeletal, dental, and cardiovascular diseases and disorders has considerably increased. This exemplifies both present and potential opportunities for biomaterials market,” said a lead TMR analyst. Furthermore, as people around the world become more susceptible to osteoporosis and arthritis, the demand for medical implants, and, subsequently biomaterials, will rise.

Product Recalls Following Incidences of Post-implantation Infections Pose Challenge for Biomaterial Manufacturers

Despite witnessing rising demand, repeated instances of post implantation infections have resulted in implant product recalls. This has been negatively impacting the sales of biomaterials used in the production of medical implants. “Medical implants are often associated with foreign body infections, which increases the cost incurred on treatment and morbidity of patients. This, combined with the increasing number of product recalls, has been limiting the sales of biomaterials,” observes the TMR report’s author. 

Besides this, the growth of this market is also held back by the Biomaterials Access Assurance Act (BAAA) 1998. Although the law was enacted to safeguard biomaterials suppliers and manufacturers, the outcome has not been as expected. Hence, several biomaterial suppliers are unwilling to provide materials due to ambiguity of immunity in lawsuits provided by BAAA against them.

Nevertheless, the advent of nanomaterials and tissue engineering is expected to revolutionize the biomaterials market. These technologies will boost sales opportunities for the market in the near future. Nanomaterials produced using nanotechnology have improved outcomes of surgeries involving the use of bone and dental implants. Therefore, leading enterprises can expect lucrative opportunities from the commercialization of the technology in the near future.

Browse Research Report on Global Biomaterials Market:
http://www.transparencymarketresearch.com/biomaterials-market.html